XGN

EXAGEN INC.

Biotechnology · Biotechnology

$313.38 sample

-1.79 (-0.57%) 1D

Market cap

$2.03T

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$313.38 +9.96% 3M daily closessample

315.17272.71

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: 10% owner
Oct 02INSInsider sell: General Counsel
Sep 29INSInsider sell: EVP, Operations
Sep 22INSInsider sell: EVP, Operations
Sep 17INSInsider sell: Chief Executive Officer
Sep 14INSInsider buy: EVP, Operations
Sep 03INSInsider sell: Chief Financial Officer
Aug 28INSInsider sell: Chief Financial Officer

Sign up to see the real XGN record →

Company facts

SEC EDGAR registration

Name: EXAGEN INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +43sample, -100 to +100
Reporting currency: USD

Who is positioning in XGN

sample

Insiders: 31 insider transactions over 90 days, net selling, $477.4M
Congress: No member trades over 90 days
Institutions · 13F: 36 funds hold $29.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$110.0B +12.5% y/y

Q4 2024Q3 2026

Inventory$64.7B +9.6% y/y

Q4 2024Q3 2026

Accounts receivable$47.6B +10.0% y/y

Q4 2024Q3 2026

Total debt$133.0B +12.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $334.2B -1.2% 3M
Sample peer B: $882.2B -10.4% 3M
Sample peer C: $1.80T -1.8% 3M
Sample peer D: $388.9B -6.5% 3M
Sample peer E: $262.0B -6.3% 3M